Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Cash from Financing Activities: 2015-2024

Historic Cash from Financing Activities for Anaptysbio (ANAB) over the last 10 years, with Dec 2024 value amounting to $127.1 million.

  • Anaptysbio's Cash from Financing Activities fell 114.59% to -$10.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$61.9 million, marking a year-over-year decrease of 165.63%. This contributed to the annual value of $127.1 million for FY2024, which is 314.27% up from last year.
  • According to the latest figures from FY2024, Anaptysbio's Cash from Financing Activities is $127.1 million, which was up 314.27% from -$59.3 million recorded in FY2023.
  • Anaptysbio's 5-year Cash from Financing Activities high stood at $252.3 million for FY2021, and its period low was -$59.3 million during FY2023.
  • Its 3-year average for Cash from Financing Activities is $37.3 million, with a median of $44.0 million in 2022.
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first skyrocketed by 28,802.84% in 2021, then crashed by 234.71% in 2023.
  • Over the past 5 years, Anaptysbio's Cash from Financing Activities (Yearly) stood at -$879,000 in 2020, then soared by 28,802.84% to $252.3 million in 2021, then plummeted by 82.55% to $44.0 million in 2022, then slumped by 234.71% to -$59.3 million in 2023, then skyrocketed by 314.27% to $127.1 million in 2024.